Vanguard Global Advisers »

Immunovant shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $835k 34k 24.84

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Immunovant

FMR
Deep Track Capital
Vanguard Group
BlackRock
Armistice Capital
Baker Bros. Advisors
T. Rowe Price Investment Management
TCG Crossover Management
Morgan Stanley
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Two Seas Capital
Jennison Associates
Rtw Investments

View all funds holding Immunovant